APA (7th ed.) Citation

Azuly, H., Shafat, T., Grupel, D., Porges, T., Abuhasira, R., Belkin, A., . . . (ESGREV), o. b. o. t. E. S. o. C. M. a. I. D. S. G. f. R. V. Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study. Adis, Springer Healthcare.

Chicago Style (17th ed.) Citation

Azuly, Hovav, et al. Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study. Adis, Springer Healthcare.

MLA (9th ed.) Citation

Azuly, Hovav, et al. Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study. Adis, Springer Healthcare.